Takeda’s shareholders are urging the company to put its $62 billion acquisition of Shire to a vote.. Lumendi received FDA 510(k) clearance for the DiLumen Is Endolumenal Interventional Scissors..

5. The reimbursement landscape is relatively stable for GI, but practice costs are steadily on the rise. “For many years GI physicians have been able to overcome significant decreases in professional ...

Motus GI Holdings Granted a U.S. Patent for a Key Feature Embodied by the Pure-Vu® System to Avoid Clogging in Cleansing the GI Tract Motus GI Holdings, Inc. Wed, Feb 21, 2024, 8:52 AM 3 min read ...